Synonyms
Mucocutaneous lymph node syndrome
Definition
Kawasaki Disease (KD) is a childhood vasculitis affecting small- and medium-sized blood vessels and manifesting classically as fever, bilateral conjunctivitis, erythema of the lips and oral mucosa, cervical lymphadenopathy, rash, and extremity changes.
Introduction
Kawasaki Disease (KD) is the second most common childhood vasculitis and the leading cause of acquired heart disease among children in the developed world (Burns and Glodé 2004). It is an acute, self-limited febrile illness of unknown cause, characterized by fever and signs of mucocutaneous inflammation. Fifteen to 25 % of untreated children develop coronary artery abnormalities, placing them at risk of developing ischemic heart disease or sudden death later in life (Kato et al. 1996). Therapy in the acute phase is aimed at reducing inflammation using intravenous immunoglobulin (IVIG), thereby minimizing the risk of coronary artery aneurysms and other late sequelae.
Diagno...
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
American Academy of Pediatrics. In: Pickering LK, editor. Red Book: 2012 report of the committee on infectious diseases. 29th ed. Elk Grove Village: American Academy of Pediatrics; 2012. p. 37–8.
Ayusawa M, Sonobe T, Uemura S, et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int. 2005;47:232.
Bowyer S, Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 year survey. Pediatric Rheumatology Database Research Group. J Rheumatol. 1996;23(11):1968–74.
Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis. 2001;184:940–3.
Burgner D, Harnden A. Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis. 2005;9:185.
Burgner D, Davila S, Breunis WB, et al. A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet. 2009;5:e1000319.
Burns JC, Glodé MP. Kawasaki syndrome. Lancet. 2004;364:533.
Burns JC, Mason WH, Glode MP, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr. 1991;118:680.
Franco A, Shimizu C, Tremoulet AH, Burns JC. Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity. 2010;43:317–24.
Fukushige J, Takahashi N, Ueda K, Hijii T, Igarashi H, Ohshima A. Long-term outcome of coronary abnormalities in patients after Kawasaki disease. Pediatr Cardiol. 1996;17(2):71.
Holman RC, Christensen KY, Belay ED, et al. Racial/ethnic differences in the incidence of kawasaki syndrome among children in Hawaii. Hawaii Med J. 2010;69(8):194-7.
Huang WC, Huang LM, Chang IS, et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003–2006. Pediatrics. 2009;123:e401–5.
Kanegaye JT, Wilder MS, Molkara D, Frazer JR, Pancheri J, Tremoulet AH, Watson VE, Best BM, Burns JC. Recognition of a Kawasaki disease shock syndrome. Pediatrics. 2009;123(5):e783–9.
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Tamakawa R. Long-term consequestions of Kawasaki disease: a 10- to 21-year follow-up study of 594 patients. Circulation. 1996;94:1379–85.
Kaveri SV. Intravenous immunoglobulin: exploiting the potential of natural antibodies. Autoimmune Rev. 2012;11:792–4.
Matsubara K, Fukaya T, Miwa K, et al. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyo-genes in Kawasaki disease. Clin Exp Immunol. 2006;143:427–34.
Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991;324:1633–9.
Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708–33.
Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, Nakamura Y, Yanagawa H, Wakui K, Fukushima Y, Kishi F, Hamamoto K, Terai M, Sato Y, Ouchi K, Saji T, Nariai A, Kaburagi Y, Yoshikawa T, Suzuki K, Tanaka T, Nagai T, Cho H, Fujino A, Sekine A, Nakamichi R, Tsunoda T, Kawasaki T, Nakamura Y, Hata A. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet. 2008;40:35–42.
Sundel RP. Update on the treatment of Kawasaki disease in childhood. Curr Rheumatol Rep. 2002;4:474.
Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics. 2010;125:e234.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Ang, E., Sundel, R. (2014). Vasculitis: Kawasaki Disease. In: Mackay, I.R., Rose, N.R., Diamond, B., Davidson, A. (eds) Encyclopedia of Medical Immunology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84828-0_394
Download citation
DOI: https://doi.org/10.1007/978-0-387-84828-0_394
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-84827-3
Online ISBN: 978-0-387-84828-0
eBook Packages: MedicineReference Module Medicine